VEDOLIZUMAB SUBCUTANEOUSLY: REAL-WORLD DATA BEFORE AND AFTER SWITCH IN IBD PATIENTS - A HESSIAN COHORT

Alica Kubesch  1     Nina Kruse  1     Üminye Balaban  2     Katharina Stratmann  2     Kathrin Sprinzl  2     Antje Dienethal  2     Mate Knabe  2     Thomas Krause  3     Stefan Zeuzem  3     Irina Blumenstein  3    
1 University-Hospital Frankfurt, Frankfurt am Main, Germany
2 University Hospital, Goethe University, Frankfurt am Main, Germany
3 Gastroenterologie Opernstraße, Kassel, Germany

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing